ArticleFrontiers in cellular and infection microbiology2018

A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis.

Cristian Rocha-Roa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.